Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of responders.
Saved in:
| Title: | Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of responders. |
|---|---|
| Authors: | Sordi V; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Monti P; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Lampasona V; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Melzi R; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Pellegrini S; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Keymeulen B; The Belgian Diabetes Registry, Academic Hospital and Diabetes Research Centre, Vrije Universiteit Brussel, Brussels, Belgium., Gillard P; Department of Endocrinology, University Hospitals Leuven-Katholieke Universiteit Leuven, Leuven, Belgium., Linn T; Clinical Research Unit, Medical Clinic and Polyclinic III, Center of Internal Medicine, Justus Liebig University, Giessen, Germany., Bosi E; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.; Università Vita-Salute San Raffaele, Milan, Italy., Rose L; Zentrum für Diabetes und Gefäßerkrankungen Münster, Munster, Germany., Pozzilli P; Department of Endocrinology and Metabolic Diseases, University Campus Bio-Medico, Rome, Italy., Giorgino F; Department of Emergency and Organ Transplantation, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy., Cossu E; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy., Piemonti L; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.; Università Vita-Salute San Raffaele, Milan, Italy. |
| Source: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Jun 20; Vol. 14, pp. 1175640. Date of Electronic Publication: 2023 Jun 20 (Print Publication: 2023). |
| Publication Type: | Randomized Controlled Trial; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37409229 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of responders. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sordi+V%22">Sordi V</searchLink>; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Monti+P%22">Monti P</searchLink>; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Lampasona+V%22">Lampasona V</searchLink>; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Melzi+R%22">Melzi R</searchLink>; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Pellegrini+S%22">Pellegrini S</searchLink>; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Keymeulen+B%22">Keymeulen B</searchLink>; The Belgian Diabetes Registry, Academic Hospital and Diabetes Research Centre, Vrije Universiteit Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Gillard+P%22">Gillard P</searchLink>; Department of Endocrinology, University Hospitals Leuven-Katholieke Universiteit Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Linn+T%22">Linn T</searchLink>; Clinical Research Unit, Medical Clinic and Polyclinic III, Center of Internal Medicine, Justus Liebig University, Giessen, Germany.<br /><searchLink fieldCode="AU" term="%22Bosi+E%22">Bosi E</searchLink>; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.; Università Vita-Salute San Raffaele, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Rose+L%22">Rose L</searchLink>; Zentrum für Diabetes und Gefäßerkrankungen Münster, Munster, Germany.<br /><searchLink fieldCode="AU" term="%22Pozzilli+P%22">Pozzilli P</searchLink>; Department of Endocrinology and Metabolic Diseases, University Campus Bio-Medico, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Giorgino+F%22">Giorgino F</searchLink>; Department of Emergency and Organ Transplantation, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Cossu+E%22">Cossu E</searchLink>; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.<br /><searchLink fieldCode="AU" term="%22Piemonti+L%22">Piemonti L</searchLink>; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.; Università Vita-Salute San Raffaele, Milan, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101555782%22">Frontiers in endocrinology</searchLink> [Front Endocrinol (Lausanne)] 2023 Jun 20; Vol. 14, pp. 1175640. <i>Date of Electronic Publication: </i>2023 Jun 20 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Randomized Controlled Trial; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101555782 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-2392 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216642392%22">16642392 </searchLink><i>NLM ISO Abbreviation: </i>Front Endocrinol (Lausanne) <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37409229 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fendo.2023.1175640 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1175640 Titles: – TitleFull: Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of responders. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sordi V – PersonEntity: Name: NameFull: Monti P – PersonEntity: Name: NameFull: Lampasona V – PersonEntity: Name: NameFull: Melzi R – PersonEntity: Name: NameFull: Pellegrini S – PersonEntity: Name: NameFull: Keymeulen B – PersonEntity: Name: NameFull: Gillard P – PersonEntity: Name: NameFull: Linn T – PersonEntity: Name: NameFull: Bosi E – PersonEntity: Name: NameFull: Rose L – PersonEntity: Name: NameFull: Pozzilli P – PersonEntity: Name: NameFull: Giorgino F – PersonEntity: Name: NameFull: Cossu E – PersonEntity: Name: NameFull: Piemonti L IsPartOfRelationships: – BibEntity: Dates: – D: 20 M: 06 Text: 2023 Jun 20 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 1664-2392 Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in endocrinology Type: main |
| ResultId | 1 |
